-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.INR↓
Mitarbeiter
2.115
Thyrocare Technologies Limited outperformed den DAX um +55 % vom 10.05.2016 bis 07.09.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von
Dir gefallen die Informationen zu Thyrocare Technologies Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Thyrocare Technologies Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Thyrocare Technologies Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Thyrocare Technologies Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
18 News & Informationen zur Thyrocare Technologies Limited Aktie
Esoteric Testing Market by Type, Technology, End-user and Region – Global Forecast to 2026
/PRNewswire/ — The “Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Genetic Testing), Technology (MS,…
Thyrocare tumbles 11.5% intra-day
Shares of Thyrocare Technologies plunged 11.5 per cent on Monday to ₹1,280.95 on the BSE during intra-day trade, as the Street gave a thumbs-down to the PharmEasy takeover deal. On Friday, PharmEay pa
Sensex retreats from record high, ends 189 pts lower as IT stocks, RIL weigh on D-Street
Investors sold IT and financial services stocks amid rising concerns over inflation.
Thyrocare Technologies share price falls 3% as IPO-bound PharmEasy acquires 66.1% stake
API Holdings Ltd (API), the parent company of PharmEasy, announced the
Thyrocare Technologies share price falls 3% as IPO-bound PharmEasy acquires 66.1% stake
API Holdings Ltd (API), the parent company of PharmEasy, announced the
Stocks To Watch: Thyrocare Technologies, InterGlobe Aviation, JSW Energy
Docon Technologies and API Holdings, the parent company of Pharmeasy, will acquire a 66.1 per cent stake in Thyrocare Technologies for Rs 4,546 crore
Buzzing Stocks: Thyrocare, Barbeque Nation, NALCO and other stocks in news today
Stocks In News: Check out the companies making the biggest headlines before the opening bell.
Trade setup for Monday: Top 10 things to know before Opening Bell
Nagaraj Shetti of HDFC Securities says the Nifty's underlying short-term trend continues to be positive with rangebound action.
Movers & Shakers | Top 10 stocks that moved the most last week
Technically, the Nifty formed a bullish Marabozu candle on the weekly charts, which suggests strength in the coming days.
IPO-bound PharmEasy buys Thyrocare; is it worth the price and what does this means for diagnostic sector?
Several analysts and competitors Moneycontrol spoke to said that the deal would be a win-win for PharmEasy and shareholders of Thyrocare and more importantly for Velumani, the Chairman of Thyrocare, who will be cashing out.
Pharmeasy Thyrocare deal: PharmEasy to acquire 66% stake in Thyrocare for over Rs 4,500 crore, Retail News, ET Retail
PharmEasy is acquiring a majority stake in diagnostics chain Thyrocare Technologies, in what the online pharmacy claimed was the first ever acquisitio..
Financial Express MSME Webinar 2021: Business Webinars, MSME Webinar by Entrepreneurs
Financial Express MSME Webinar 2021: Join our small business webinar on small scale industries, their scope and development by leading industrial experts & entrepreneurs. Register online for MSME webinar between June 15th to June 30th. Also Check out the latest news on MSME Industry and expert analysis here.
Pharmeasy To Acquire Thyrocare In Rs 4,546 Crore-Deal
Shares of Thyrocare closed 6.23 per cent up at Rs 1,448.05 apiece on BSE on Friday., , PharmEasy, thyrocare, Digital healthcare company, a velumani, API Holdings
Pharmeasy to acquire 66% stake in Thyrocare for Rs 4,546 crore
Docon Technologies Private Limited, a subsidiary of API Holdings, has also made an open offer for acquiring 26 per cent stake in Thyrocare.
Pharmeasy to acquire 66% stake in Thyrocare for Rs 4,546 crore
Docon Technologies Private Limited, a subsidiary of API Holdings, has also made an open offer for acquiring 26 per cent stake in Thyrocare.
Pharmeasy To Acquire Thyrocare In Rs 4,546 Cr Deal
Digital healthcare company Pharmeasy on Friday announced that it will acquire a controlling stake in diagnostic chain Thyrocare for Rs 4,546 crore. API Holdings, the parent of the unicorn Pharmeasy, and A Velumani, Chairman and Managing Director of Thyrocare Technologies, have signed a definitive agreement for the deal.
Sensex ends 226 pts higher as bank, metal stocks lift Dalal Street; RIL down 2%
Traders on Dalal Street cheered firm global cues.
Sensex retreats 600 points from day's high, Nifty ends below 15,700; PNB rises 2%
Global cues were positive after the Fed Reserve chairman cleared air on rate hike talks and said the central bank will continue to support the economy and job creation.